Catheter Precision shares surge 67.90% premarket after acquiring Flyte, Ponderosa for $11.55M and launching $35.56M financing.

Catheter Precision surged 67.90% in premarket trading following the announcement of a $11.55 million acquisition of 80.02% of Flyte and 100% of Ponderosa from Creatd, alongside a $1.85 million initial close of a multi-tranche private placement of preferred stock with an option to raise up to $35.56 million. The transactions, structured to restructure legacy businesses, simplify the balance sheet, and expand the operating platform, included cash, a 0% note, and Series D preferred stock. The capital raise and strategic acquisitions signal growth potential, while resale registration rights for investors and Creatd further enhance liquidity prospects. The moves align with the company’s focus on platform expansion and operational simplification, directly supporting the sharp premarket price increase.